IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $446,000 | -57.8% | 9,931 | -46.9% | 0.04% | -55.8% |
| Q4 2020 | $1,056,000 | -62.4% | 18,685 | -59.9% | 0.09% | +1.2% |
| Q4 2019 | $2,811,000 | -68.3% | 46,546 | -66.3% | 0.08% | -75.3% |
| Q2 2019 | $8,877,000 | +89.8% | 138,126 | +139.6% | 0.34% | +27.4% |
| Q1 2019 | $4,678,000 | +1371.1% | 57,639 | +876.9% | 0.27% | +1587.5% |
| Q4 2018 | $318,000 | -66.1% | 5,900 | -67.6% | 0.02% | -51.5% |
| Q3 2018 | $938,000 | -79.7% | 18,200 | -80.0% | 0.03% | -52.9% |
| Q2 2017 | $4,629,000 | +286.7% | 91,000 | +77.0% | 0.07% | +25.0% |
| Q2 2016 | $1,197,000 | -37.4% | 51,400 | +66.3% | 0.06% | -51.7% |
| Q4 2015 | $1,913,000 | – | 30,900 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |